Harmony Biosciences Holdings, Inc.
BP-205
Countdown
56days
Phase 1 readout · ~ Aug 31, 2026 estimated
What's at stake
Phase 1 trial results for BP-205 in its lead indication are due ~ Aug 31, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 13h ago
“Phase 1 SAD/MAD clinical study ongoing in Europe; on track for clinical PK, safety, and tolerability data from SAD phase in mid-2026”